The Venture Codex Logo

The Venture Codex

Dawn Biopharma

2711 Centerville Rd, Wilmington, Delaware, 19808, United States

Overview

Global investment firm.

Founded

2022

Deals · 12mo

4

Links

LinkedIn

Stage focus

Multi-stage

Geographic focus

Belgium
Denmark
France
United States

Sector focus

—

Investment portfolio

11rounds
NAMEDATESIZE
Expedition Therapeutics
Aug 2026Participated
$115 MSeries B
Vedana Therapeutics
Jun 2026Participated
$46 MSeries A
ADCendo
Apr 2026Participated
$76 MSeries C
Adcytherix
Oct 2025Participated
$122 MSeries A
Expedition Therapeutics
Oct 2025Participated
$165 MSeries A
Antag Therapeutics
Dec 2024Participated
$93 MSeries A
ADCendo
Nov 2024Participated
$135 MSeries B
Bambusa Therapeutics
Sep 2024Led
$15 MSeed
Adcytherix
Jun 2024Participated
$32 MSeed
ADCendo
May 2024Led
$17 MSeries A
AgomAb Therapeutics
Oct 2023Participated
$100 MSeries C
Expedition Therapeutics
Aug 2026Participated
$115 MSeries B
Vedana Therapeutics
Jun 2026Participated
$46 MSeries A
ADCendo
Apr 2026Participated
$76 MSeries C
Adcytherix
Oct 2025Participated
$122 MSeries A
Expedition Therapeutics
Oct 2025Participated
$165 MSeries A
Antag Therapeutics
Dec 2024Participated
$93 MSeries A
ADCendo
Nov 2024Participated
$135 MSeries B
Bambusa Therapeutics
Sep 2024Led
$15 MSeed
Adcytherix
Jun 2024Participated
$32 MSeed
ADCendo
May 2024Led
$17 MSeries A
AgomAb Therapeutics
Oct 2023Participated
$100 MSeries C
11
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Dawn Biopharma: 11 funding rounds are recorded in the selected participation categories.All available history.
Dawn Biopharma: 11 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed11
Series A14
Series B02
Series C+02

Monthly Deal Activity

Dawn Biopharma: 11 deals are recorded across 37 months.All available history.
Dawn Biopharma: 11 deals are recorded across 37 months. All available history
MonthDeals
Oct '231
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '241
Jun '241
Jul '240
Aug '240
Sep '241
Oct '240
Nov '241
Dec '241
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '252
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '261
May '260
Jun '261
Jul '260
Aug '261
Sep '260
Oct '260

Sector Breakdown

Dawn Biopharma: Health & Life Sciences is the largest displayed sector by deal count (11 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Dawn Biopharma: Health & Life Sciences is the largest displayed sector by deal count (11 deals). All available history
SectorDeals
Health & Life Sciences11

Deal Size Distribution

Dawn Biopharma: 11 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Dawn Biopharma: 11 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M2
$25M-$50M2
$50M-$100M2
$100M-$250M5
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Dawn Biopharma: Europe has the largest recorded deal count among the displayed regions (7 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Dawn Biopharma: Europe has the largest recorded deal count among the displayed regions (7 deals). All available history
RegionDeals
Europe7
United States4
Dawn Biopharma: 20 co-investors are shown, with Novo Holdings sharing 6 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Dawn Biopharma: 20 co-investors are shown, with Novo Holdings sharing 6 recorded deals. All available history
Co-investorShared deals
Novo Holdings6
Pontifax5
RA Capital Management5
Logos Capital4
Venrock4
BVF Partners3
Gilde Healthcare3
HealthCap3
Surveyor Capital3
Ysios Capital3
Balyasny Asset Management2
Bpifrance2
Canaan Partners2
EIFO2
Forbion2
OrbiMed2
Pureos Bioventures2
Sanofi Ventures2
Sofinnova Ventures2
TCGX2

Investment Strategy

Dawn Biopharma: Led accounts for 18% and participating for 82% of round participation.All available history.
Dawn Biopharma: Led accounts for 18% and participating for 82% of round participation. All available history
CategoryDeals (count)Share (%)
Led218%
Participating982%
Dawn Biopharma: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
Dawn Biopharma: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead150%
Co-led150%

Team

Iyona Rajkomar, MBBS, CFA